Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling (Q1782097)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling |
scientific article; zbMATH DE number 6938685
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling |
scientific article; zbMATH DE number 6938685 |
Statements
Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling (English)
0 references
18 September 2018
0 references
adaptive Bayesian design
0 references
Bliss independence
0 references
drug combination
0 references
dose finding
0 references
interaction index function
0 references
maximum tolerated dose (MTD)
0 references
maximum tolerated region
0 references
objective function
0 references
0.88483644
0 references
0.8821615
0 references
0.87064826
0 references
0.86220276
0 references
0.85832644
0 references
0.85694516
0 references
0.8543349
0 references
